Research Paper Volume 13, Issue 9 pp 12514—12525

Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells

Schematic illustration depicting the roles of capsanthin in suppressing tumor progression of TNBC.

Figure 6. Schematic illustration depicting the roles of capsanthin in suppressing tumor progression of TNBC.